Clinical trial
Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B
NCT00309543 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00309543 |
|---|---|
| Title | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B |
| Official title | A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0). |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colon Cancer Stage II |
| Intervention type | Drug |
| Interventions | Fluorouracil, Leucovorin |
| Enrollment | 636 |
| Start date | Nov 1, 1993 |
| First posted | Apr 3, 2006 |
| Last update posted | Apr 3, 2006 |
| Countries | Austria |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: